Skip to main content
. 2013 May;33(10):1916–1924. doi: 10.1128/MCB.00015-13

Fig 10.

Fig 10

Effect of a Bax blocking peptide on kidney function after renal ischemia in vivo. Shown is the effect of a cell-permeable NPM-Bax blocking peptide (NPM-Bax peptide), versus a nonspecific (control) peptide, on kidney function (BUN) on days 1 to 4 after 25 min of ischemia; 100 μg/g peptide was administered 30 min before and again 30 min after ischemia; n = 6 mice per group; *, P < 0.05 versus control peptide.